Stay updated with breaking news from Nasdaq Lsta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lisata Therapeutics, Inc. (NASDAQ:LSTA – Get Free Report) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 54,600 shares, a growth of 10.5% from the October 15th total of 49,400 shares. Approximately 0.8% of the company’s stock are sold short. Based on an […]
Lisata Therapeutics (NASDAQ:LSTA – Get Free Report) and Mangoceuticals (NASDAQ:MGRX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Earnings and Valuation This table compares Lisata Therapeutics […]
Lisata Therapeutics (NASDAQ:LSTA – Get Free Report) issued its earnings results on Monday. The company reported ($0.50) EPS for the quarter, beating analysts’ consensus estimates of ($0.70) by $0.20, reports. Lisata Therapeutics Trading Down 0.7 % NASDAQ:LSTA opened at $2.68 on Thursday. The firm’s fifty day simple moving average is $3.54 and its 200 day […]
Lisata Therapeutics (NASDAQ:LSTA – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.50) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.70) by $0.20, reports. Lisata Therapeutics Stock Performance Lisata Therapeutics stock opened at $2.68 on Thursday. Lisata Therapeutics has a one year low of $2.36 and […]
Lisata Therapeutics (NASDAQ:LSTA – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Monday, August 14th. Analysts expect Lisata Therapeutics to post earnings of ($0.70) per share for the quarter. Lisata Therapeutics (NASDAQ:LSTA – Get Free Report) last issued its quarterly earnings data on Tuesday, May 9th. The […]